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SUMMARY 
A highl y-sensitile tlourescence method, capable of detecting cytokine receptors present at low 
concentrations (around I DO molecules per cell) by flow cytometry, was adapted for use on tissue 
sections. Thi s method was used to examine the expression of several cytokine receptors in 
lymphoid ti ss ues. lL-2 receptors were distributed broadly, with higher concentrations in T cell 
areas. lL-1 receptor Type I was detected in T cell areas and in the follicular mantle, and was 
strongly expressed on vasc ular endothelium. IL-6 receptor was found at very low concentration , 
both within and outside germinal centres. The gp 130 molecule, which is involved in the functional 
receptor complex for IL-6 and several other cytokines, was present at higher concentrations, 
particularl y in the germinal centre . Analysis of receptor expression in secondary lymphoid tissue 
provides evidence bearing on the physiological roles of cytokines, as these tissues contain cell s 
at variou s stages of physiological activation located in well-defined functional zones. 
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INTRODUCTION 
Cytokines control many aspects of the immune and haematopoietic systems, includ-
ing the production, proliferation, differentiation, activation and migration of lymphoid 
and myeloid cells . Cytokine-responsive cells bear specific cytokine receptors. These are 
often two- or three-chain structures, with one chain interacting specifically with a single 
cytokine whilst the second chain, which usually confers high affinity on the interaction 
and transduces signals to the cell , may be shared by several cytokines (Taga and 
Kishimoto , 1992; Kondo et at., 1993; Noguchi et at., 1993). 
Analysis of cytokine receptor expression by lymphoid and myeloid cell populations 
is useful in understanding the details of cytokine action, and may shed light on 
pathological as well as physiological processes. There have been many studies reporting 
cytokine receptor expression on circulating lymphocytes, and other studies reporting 
soluble receptor levels in the circulation, in health and in a variety of pathological 
conditions (for a review and commentary, see Zola, 1992 and 1994). However, studies 
Correspondence to: Prof. Heddy Zola, Deputy Director, Child Health Research Institute, Women's 
and Children's Hospital, North Adelaide SA5006, Australia. Tel.: 618 2047015; Fax: 618 239 0267. 
© 1995 Asfra B.V. Received 20 May 1995 
148 H .  ZOLA ET AL. 
o f  c y t o k i n e  r e c e p t o r  e x p r e s s i o n  in s e c o n d a r y  l y m p h o i d  t i s s u e  h a v e  b e e n  l i m i t e d .  A 
n u m b e r  o f  i m m u n o h i s t o c h e m i c a l  s t u d i e s  o f  c y t o k i n e  r e c e p t o r  a n t i b o d i e s  w e r e  p r e s e n t e d  
at the 5 t h  I n t e r n a t i o n a l  L e u c o c y t e  T y p i n g  W o r k s h o p  ( A u t s c h b a c h  et at., 1993; D e  W e g e r  
et at., 1 9 9 3 ;  B e r t i  et at., 1 9 9 3 ;  Z o l a  et at., 1 9 9 3 d ) .  T h e s e  s t u d i e s  p r o d u c e d  v a l u a b l e  
r e s u l t s ,  b u t  a c o m m o n  f i n d i n g  was t h a t  r e a c t i v i t y  w a s  v a r i a b l e  a n d  g e n e r a l l y  w e a k ,  
p r e s u m a b l y  b e c a u s e  o f  t h e  l o w  l e v e l s  o f  c y t o k i n e  r e c e p t o r  e x p r e s s i o n  ( A u t s c h b a c h  et at., 
1993). T i s s u e  s t u d i e s  a r e  n e e d e d  to f u r t h e r  e l u c i d a t e  c y t o k i n e  f u n c t i o n ,  as s e c o n d a r y  
l y m p h o i d  t i s s u e s  a r e  the s i t e  o f  i m p o r t a n t  i m m u n o l o g i c a l  p r o c e s s e s ,  s u c h  as c o g n a t e  T 
c e l l l B  c e l l  i n t e r a c t i o n  a n d  g e r m i n a l  c e n t r e  ( G C )  r e a c t i o n s .  F u r t h e r m o r e ,  the s t u d i e s  n e e d  
to b e  d o n e  o n  t i s s u e  s e c t i o n s  a n d  n o t  j u s t  o n  c e l l  s u s p e n s i o n s ,  in o r d e r  to p r e s e r v e  t h e  
s p a t i a l  r e l a t i o n s h i p s  b e t w e e n  c e l l s ,  w h i c h  a r e  e s s e n t i a l  f o r  in vivo i m m u n e  r e s p o n s e s .  
C y t o k i n e s  c a n  m e d i a t e  t h e i r  e f f e c t s  o n  c e l l s  w h i c h  b e a r  v e r y  l o w  c o n c e n t r a t i o n s  o f  
r e c e p t o r  ( r a n g i n g  f r o m  10 to a f e w  h u n d r e d  m o l e c u l e s  p e r  c e l l ) ,  w h i l e  c o n v e n t i o n a l  
s t a i n i n g  t e c h n i q u e s  d e t e c t  m o l e c u l e s  p r e s e n t  a t  c o n c e n t r a t i o n s  o f  s e v e r a l  t h o u s a n d  p e r l  
c e l l  ( Z o l a ,  1994; Z o l a  et al., 1 9 9 0 b ) .  F o r  e x a m p l e ,  I L - J  a c t s  on t h y m o c y t e s  e x p r e s s i n g  
l e s s  t h a n  100 m o l e c u l e s  o f  r e c e p t o r  ( D o w e r  et aI., 1 9 8 5 ) ,  w h i l e  I L - 4  a c t s  o n  B c e l l s  
e x p r e s s i n g  a r o u n d  4 0 0  m o l e c u l e s  o f  r e c e p t o r  p e r  c e l l  ( L o w e n t h a l  et aI., 1 9 8 8 ) .  T h i s  h a s  
n e c e s s i t a t e d  t h e  d e v e l o p m e n t  o f  f l u o r e s e n c e  s t a i n i n g  a n d  f l o w  c y t o m e t r i c  m e t h o d s  
c a p a b l e  o f  h i g h  s e n s i t i v i t y  in o r d e r  to e x a m i n e  c y t o k i n e  r e c e p t o r  e x p r e s s i o n  by l y m p h o i d  
f u n c t i o n a l  s u b - p o p u l a t i o n s  (Zolaet a!., 1989, 1 9 9 0 b ;  O l w e u s  eta!., 1993; C o v e n t r y  et aI., 
1 9 9 4 ;  Z o l a ,  1 9 9 5 ) .  
In t h e  c u r r e n t  s t u d y  w e  a d a p t e d  o u r  h i g h - s e n s i t i v i t y  f l o w  c y t o m e t r i c  p r o c e d u r e s  to 
mjcroscopy, and examined the expression of cytokine receptors in solid tissue. 
M A  T E R I A L S  A N D  M E T H O D S  
Monoclonal antibodies. T h e  m o n o c l o n a l  a n t i b o d i e s  a g a i n s t  c y t o k i n e  r e c e p t o r s  a r e  
d e s c r i b e d  in T a b l e  1. A d d i t i o n a l  m o n o c l o n a l  a n t i b o d i e s  used w e r e :  a n t i - I g D :  H B 7 0  
( A T C C )  ( K u r i t a n i  a n d  C o o p e r ,  1 9 8 2 ) ;  C D I 9 :  F M C 6 3  CZola et al., 1 9 9 0 a ) ;  C D 3 :  O K T 3  
( A T C C )  ( K u n g  et al., 1979) C D 3 8 - F I T C  ( P h a r M i n g e n ,  S a n  D i e g o ,  C a . ) .  
Tissue preparing and staining. L y m p h o i d  t i s s u e  was o b t a i n e d  f r e s h  a n d  c u t  i n t o  b l o c k s  
( 5 - l O m m 3 ) w h i c h  w e r e  s n a p - f r o z e n  in O C T  c o m p o u n d  ( M i l e s  L a b o r a t o r i e s ,  E l k h a r t ,  
I n . ) .  F r o z e n  t i s s u e  b l o c k s  w e r e  s t o r e d  at 8 0 ' C .  C r y o s t a t  s e c t i o n s  (6Ilm) w e r e  p l a c e d  o n  
g e l a t i n - c o a t e d  s l i d e s  a n d  a i r - d r i e d  o v e r n i g h t ,  to e n s u r e  a d h e r e n c e  to the s l i d e .  A w a x  p e n  
was u s e d  to d r a w  a c i r c l e  r o u n d  the s e c t i o n s ,  to c o n t a i n  the r e a g e n t s  on the s l i d e .  S e c t i o n s  
w e r e  b l o c k e d  w i t h  3% B S A  in t r i s - b u f f e r e d  s a l i n e  ( T B S )  f o r  3 0  min. A l l  i n c u b a t i o n s  w e r e  
p e r f o r m e d  at r o o m  t e m p e r a t u r e  in a h u m i d i f i e d  c h a m b e r , a n d  w e r e  f o l l o w e d  by w a s h i n g  
w i t h  s t i r r i n g  f o r  5 m i n  in T B S  c o n t a i n i n g  1 % B S A .  A f t e r  e a c h  w a s h ,  e x c e s s  l i q u i d  was 
r e m o v e d  by g e n t l e  b l o t t i n g  w i t h  p a p e r  t i s s u e ,  i m m e d i a t e l y  b e f o r e  t h e  a d d i t i o n  o f t h e  n e x t  
r e a g e n t  (to a v o i d  d r y i n g - o u t ) .  
M o n o c l o n a l  a n t i b o d y  (I 0 0 / l L )  w a s  p l a c e d  o n  t h e  s p e c i m e n ,  at a d i l u t i o n  ( i n  TBSI 
I % B S A )  s h o w n  by p r e l i m i n a r y  t i t r a t i o n  to g i v e  o p t i m a l  s t a i n i n g  w i t h  m i n i m a l  b a c k -
g r o u n d  s t a i n i n g .  T h i s  was u s u a l l y  a 1 0 - 2 0 - f o 1 d  l o w e r  c o n c e n t r a t i o n  t h a n  u s e d  f o r  flo\\ 
c y t o m e t r i c  a n a l y s i s .  T h e  s l i d e s  w e r e  i n c u b a t e d  as d e s c r i b e d  a n d  t h e n  w a s h e d  t \ \ i c e . 
B o u n d  a n t i b o d y  w a s  d e t e c t e d  by t h r e e  d i f f e r e n t  m e t h o d s ,  w h i c h  w e r e  c o m p a r e d  for 
s e n s i t i v i t y .  
C Y T O K I N E  R E C E P T O R S  I N  [ H U M A N ]  L Y M P H O I D  T I S S U E  1 4 9  
T a b l e  1. M o n o c l o n a l  a n t i b o d i e s  a g a i n s t  c y t o k i n e  r e c e p t o r s  u s e d  i n  t h i s  s t u d y .  
R e c e p t o r  C D  n u m b e r  A n t i b o d y  Ig T y p e  S o u r c e / r e f e r e n c e  
I L - l  t y p e  1 C D 1 2 1 a  4 C 1  R a t  I g G 2 a  P h a r M i n g e n  
I L - 2 a  ( p 5 5 )  C D 2 5  7 G 7 B 6  M o u s e  I g G 2 a  R u b i n  et al. ( 1 9 8 5 )  
IL-2~ ( p 7 5 )  C D I 2 2  Mik~l M o u s e  I g G 2 a  T s u d o  et al. (1989) 
I L - 2 y  ( p 6 4 )  N o t  c l u s t e r e d  T U G h 4  R a t  I g G 2 b  I s h i i  et al. ( 1 9 9 4 )  
I L - 4  C D w 1 2 4  h - I L - 4 R  M 5 7  M o u s e  I g G l  L T V *  
I L - 6  ( p 8 0 )  C D I 2 6  M T I 8  M o u s e  I g G 2 b  L T V  
g p 1 3 0  C D w 1 3 0  A M 6 4  M o u s e  I g G  L T V  
I L - 7  C D w 1 2 7  h - I L - 7 R  M 2 0  M o u s e  I g G l  L T V  
T N F T y p e  I C D I 2 0 a  h t r - 9  M o u s e  I g G l  L T V  
T N F  T y p e  2 C D l 2 0 b  u t r - I  M o u s e  I g G l  L T V  
c - k i t  C D l 1 7  Y B 5 B 8  M o u s e  I g G l  L T V  
* L T V :  L e u c o c y t e  T y p i n g  V: 5 t h  I n t e r n a t i o n a l  W o r k s h o p  o n  H u m a n  L e u c o c y te D i f f e r e n t i a t i o n  A n t i g e n s .  
Three-stage immunofluorescence method. B o u n d  m o n o c l o n a l  a n t i b o d y  w a s  d e t e c t e d  
w i t h  b i o t i n y l a t e d  h o r s e  a n t i - m o u s e  I g  ( V e c t o r  L a b o r a t o r i e s ,  B u r l i n g a m e ,  C a . ,  c a t a l o g  # 
B A - 2 0 0 0 )  (100!1L). T h i s  r e a g e n t  r e q u i r e d  a b s o r p t i o n  w i t h  t o n s i l  c e l l s  to r e d u c e  n o n -
s p e c i f i c  s t a i n i n g .  A b s o r p t i o n  w a s  c a r r i e d  o u t  w i t h  10 8 f r e s h  o r  c r y o p r e s e r v e d  t o n s i l  c e l l s  
p e r  m L  o f  a n t i b o d y  a t  I I I  0 0  d i l u t i o n , f o r  1 h r  o n  i c e ,  w i t h  o c c a s i o n a l  m i x i n g . P r e l i m i n a r y  
t i t r a t i o n  i n d i c a t e d  o p t i m a l  s t a i n i n g  a t  11250 d i l u t i o n  ( i . e .  112.5 o f  t h e  a b s o r b e d  m a t e r i a l ) . 
S l i d e s  w e r e  i n c u b a t e d  f o r  1 h r  a n d  w a s h e d  a s  d e s c r i b e d ,  a n d  t h e  b o u n d  b i o t i n  w a s  t h e n  
v i s u a l i s e d  u s i n g  C y 3 - s t r e p t a v i d i n  ( J a c k s o n  I m m u n o R e s e a r c h ,  W e s t  G r o v e ,  P a . ,  c a t a l o g  
# 0 1 6 - 1 6 0 - 0 8 4 ) ,  100!1L o f  a 1 / 5 0 0  d i l u t i o n .  S l i d e s  w e r e  a g a i n  i n c u b a t e d  a n d  w a s h e d  as 
a b o v e , a f t e r  w h i c h  e x c e s s  b u f f e r  w a s  r e m o v e d  b y  g e n t l y  b l o t t i n g  w i t h  t i s s u e  p a p e r .  S l i d e s  
w e r e  m o u n t e d  in 9 0 %  g l y c e r o l  i n  p h o s p h a t e - b u f f e r e d  s a l i n e ,  c o n t a i n i n g  D A B C O  t o  
r e d u c e  f a d i n g .  
Two-stage immunofluorescence method. T h i s  m e t h o d  w a s  s i m i l a r  to the t h r e e - s t a g e  
m e t h o d , e x c e p t  t h a t  b o u n d  m o n o c l o n a l  a n t i b o d y  was d e t e c t e d  d i r e c t l y  u s i n g  C y - 3 - l a b e l l e d  
a n t i - m o u s e  19 ( J a c k s o n  I m m u n o R e s e a r c h ,  W e s t  G r o v e ,  P a . ,  c a t a l o g  # 1 1 5 - 1 6 6 - 0 6 2 ) .  
Immunoperoxidase. T h i s  m e t h o d  w a s  c a r r i e d  o u t  as d e s c r i b e d  p r e v i o u s l y  ( C o v e n t r y  et 
al., 1 9 9 4 ) .  T h e  t e c h n i q u e  is s i m i l a r  in p r i n c i p l e  to t h e  t h r e e - s t a g e  m e t h o d ,  b u t  u t i l i s e s  
e n z y m e  i n s t e a d  o f  f l u o r o c h r o m e .  T h e  r e a g e n t s  u s e d  w e r e  b i o t i n y l a t e d  r a b b i t  a n t i - m o u s e  
I g  ( D a k o , G l o s t r u p ,  D e n m a r k ,  c a t a l o g  # E 3 5 4 )  f o l l o w e d  b y  s t e p t a v i d i n - h o r s e r a d i s h  
p e r o x i d a s e  ( P i e r c e ,  R o c k f o r d ,  II., c a t a l o g  # 2 1 1 2 4 ) .  
Fluorescence microscopy. A n u m b e r  o f  d i f f e r e n t  f l u o r e s c e n c e  m i c r o s c o p e s  w e r e  u s e d  in 
t h e  c o u r s e  o f  t h i s  s t u d y ,  a n d  s i g n i f i c a n t  d i f f e r e n c e s  w e r e  f o u n d  in s e n s i t i v i t y .  T h e  C y 3  was 
well v i s u a l i s e d  u s i n g  f i l t e r  b l o c k s  i n t e n d e d  f o r  use w i t h  r h o d a m i n e , s u c h  as t h e  L e i c a  N 2 . 1 
b l o c k  ( e x c i t a t i o n  f i l t e r  5 1 5 - 5 6 0  n m ,  d i c h r o i c  m i r r o r  at 5 8 0  n m  a n d  b a r r i e r  f i l t e r  at 5 8 0  nm) 
o r  L e i c a  M 2  ( e x c i t a t i o n  f i l t e r  5 4 6 ±  14 nm, o t h e r w i s e  as N 2 . 1 ) .  T h e  c h o i c e  o f  l e n s  was 
i m p o r t a n t ,  w i t h  i m m e r s i o n  l e n s e s  o f  h i g h  n u m e r i c a l  a p e r t u r e  g i v i n g  t h e  h i g h e s t  s e n s i t i v i t y . 
ISO H .  Z O L A  ET AL. 
Cell suspension studies. C e l l s  in s u s p e n s i o n  w e r e  s t a i n e d  a n d  a n a l y s e d  by f l o w  c y t o m e t r y  
as d e s c r i b e d  e l s e w h e r e  ( Z o l a  et aI., 1990b; Z o l a ,  1 9 9 5 ) .  F o r  e x a m i n a t i o n  in t h e  
m i c r o s c o p e ,  s t a i n e d  c e l l s  w e r e  d e p o s i t e d  on s l i d e s  u s i n g  a c y t o c e n t r i f u g e .  
R E S U L T S  
Comparison of fluorochromes 
Phycoerythrin. T h i s  f l u o r o c h r o m e  g i v e s  t h e  h i g h e s t  s e n s i t i v i t y  by f l o w  c y t o m e t r y .  
H o w e v e r ,  w h e n  e x a m i n e d  by f l u o r e s c e n c e  m i c r o s c o p y ,  P E  f l u o r e s c e n c e  f a d e d  w i t h i n  
s e c o n d s  u n d e r  m i c r o s c o p e  i l l u m i n a t i o n ,  m a k i n g  i m a g e  c a p t u r e  a n d  e x a m i n a t i o n  i m p r a c -
tical. A n u m b e r  o f  a n t i - f a d i n g  a g e n t s  w e r e  e x a m i n e d ,  i n c l u d i n g  D A B C O ,  w h i c h  is e f f e c t i v e  
in r e d u c i n g  f a d i n g  o f  f l u o r e s c e i n ,  a n d  r e a g e n t s  m a r k e t e d  s p e c i f i c a l l y  f o r  use w i t h  P E  
( A F 2 3 ,  A F 9 3 ,  A F l l 3 ,  A F 1 3 3 ; C i t i f l u o r ,  A g a r  S c i e n t i f i c ,  S t a n s t e d ,  E s s e x ,  U K ) ,  b u t  f a d i n g  
w a s  still t o o  r a p i d  to a l l o w  i m a g e  c a p t u r e  and e x a m i n a t i o n .  R a p i d  i m a g e  c a p t u r e ,  u s i n g  a 
h i g h l y - s e n s i t i v e  v i d e o  c a m e r a ,  w a s  a t t e m p t e d , b u t  it w a s  d i f f i c u l t  to f o c u s  a n d  s e l e c t  a f i e l d  
f o r  i m a g e  c a p t u r e  w i t h o u t  l o s i n g  m u c h  o f  t h e  f l u o r e s c e n c e .  In an a t t e m p t  to s t a b i l i s e  
f l u o r e s c e n c e , s e c t i o n s  w e r e  f i x e d  d i r e c t l y  a f t e r  s t a i n i n g  a n d  b e f o r e  m o u n t i n g .  S e c t i o n s  
fixed by b r i e f  i m m e r s i o n  in a c e t o n e  s h o w e d  a s i g n i f i c a n t  r e d u c t i o n  in f a d i n g , w h i c h  w a s  
o b v i o u s  up to 4 8  h r  a f t e r  s t a i n i n g ,  b u t  f i x i n g  r e d u c e d  s t a i n i n g  i n t e n s i t y ,  a n d  P E - l a b e l l e d  
s a m p l e s  d i d  n o t  a p p e a r  as b r i g h t  as s a m p l e s  s t a i n e d  w i t h  C y 3  ( s e e  b e l o w ) .  A n u m b e r  o f  
v a r i a t i o n s  in f i x a t i v e  and c o n d i t i o n s  o f  f i x a t i o n  d i d  n o t  i m p r o v e  t h e  r e t e n t i o n  o f  s t a i n i n g . 
Cy-3. C y - 3  g a v e  i n t e n s e  r e d  s t a i n i n g  t h a t  a p p e a r e d  b y  e y e  to b e  as b r i g h t  as P E  s t a i n i n g .  
S i n c e  t h e  e x t i n c t i o n  c o e f f i c i e n t  a n d  q u a n t u m  y i e l d  o f  C y - 3  ( 1 3 0 , 0 0 0  a n d  0 . 1 5 )  a r e  l o w e r  
t h a n  t h o s e  o f P E  ( 2 , 0 0 0 , 0 0 0  a n d  0 . 8 )  t h e  l a t t e r  s h o u l d  b e  c a p a b l e  o f  g i v i n g  a m u c h  b r i g h t e r  
s i g n a l ,  b u t  f a d i n g  n e g a t e s  t h e  t h e o r e t i c a l  a d v a n t a g e s  o f  PE. 
Comparison of staining protocols 
S t a i n i n g  w a s  c a r r i e d  o u t  u s i n g  t w o - s t a g e  a n d  t h r e e - s t a g e  p r o t o c o l s  as d e s c r i b e d .  
F i g u r e  1 a n d  F i g u r e  2 s h o w  t h a t  s t a i n i n g  w a s  b r i g h t e r  u s i n g  t h e  t h r e e - s t a g e  p r o t o c o l .  
Sensitivity of the Cy-3 system 
In o r d e r  to q u a n t i f y  t h e  s e n s i t i v i t y  o f  t h e  C y - 3  s y s t e m  in c o m p a r i s o n  w i t h  t h e  
e x t e n s i v e l y - c h a r a c t e r i s e d  P E  s y s t e m ,  s a m p l e s  o f  c e l l s  w e r e  s t a i n e d  in s u s p e n s i o n  w i t h  
m o n o c l o n a l  a n t i b o d y  f o l l o w e d  b y  b i o t i n y l a t e d  h o r s e  a n i t - m o u s e  Ig. T h e y  w e r e  t h e n  
s t a i n e d  e i t h e r  w i t h  P E - s t r e p t a v i d i n  ( C a l t a g ,  S a n  F r a n c i s c o ,  C a . ,  c a t a l o g  # S A  1 0 0 4 - 4 )  f o r  
f l o w  c y t o m e t r y  o r  C y - 3  s t r e p t a v i d i n  f o r  c y t o c e n t r i f u g a t i o n  a n d  m i c r o s c o p y .  T h e  c y t o -
c e n t r i f u g e  p r e p a r a t i o n s  w e r e  e x a m i n e d  u s i n g  a l t e r n a t i v e l y  p h a s e  c o n t r a s t  ( N o r m a r s k i )  
a n d  d a r k - f i e l d  f l u o r e s c e n c e  e p i - i l l u m i n a t i o n  to c o u n t  t h e  p r o p o r t i o n  o f  c e l l s  s t a i n e d .  
F l o w  c y t o m e t r i c  r e s u l t s  a r e  s h o w n  i n  F i g u r e  3, a n d  t h e  p r o p o r t i o n  o f  c e l l s  c o u n t e d  as 
p o s i t i v e  i n  t h e  c y t o c e n t r i f u g e  p r e p a r a t i o n s  a r e  g i v e n  in t h e  F i g u r e  c a p t i o n  f o r  c o m p a r i -
son. T h e s e  r e s u l t s  i n d i c a t e  t h a t  C y - 3  f l u o r e s c e n c e  m i c r o s c o p y  a l l o w s  s e n s i t i v i t y  a p p r o x i -
m a t e l y  e q u a l  to t h a t  o f  f l o w  c y t o m e t r y  w i t h  P E .  X 6 3  is a n e g a t i v e  c o n t r o l , w h i l e  O K T 3  
is i n c l u d e d  to c h e c k  t h a t  t h e  n u m b e r  o f  u n - s t a i n e d  c e l l s  is n o t  b e i n g  u n d e r e s t i m a t e d in 
p h a s e - c o n t r a s t  m i c r o s c o p y .  
In a s e p a r a t e  e x p e r i m e n t ,  t o n s i l  s e c t i o n s  w e r e  s t a i n e d  by C y - 3  for ill1ll1un o tlu o r e s -
c e n c e  a n d  by i l l 1 m u n o p e r o x i d a s e . R e s u l t s  a r e  s h o w n  in F i g u r e  -+. T h e  te ch ni que.; \ \ e re 
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CD25 CD3 
CD25 CD3 
F i g u r e  I. F l o w  c y t o m e t r i c  a n a l y s i s  o f  C y - 3  f l u o r e s c e n c e ,  c o m p a r i n g  t w o - s t a g e  ( u p p e r  p a t t e r n s )  a n d  t h r e e -
s t a g e  ( l o w e r  p a t t e r n s )  s t a i n i n g  w i t h  C D 3  a n d  C D 2 5 .  E a c h  h i s t o g r a m  is s h o w n  s u p e r i m p o s e d  o n  a n e g a t i v e  
c o n t r o l  a n t i b o d y .  T h e  g r e a t e r  s e n s i t i v i t y  o f  t h e  t h r e e - s t a g e  m e t h o d  is s e e n  w i t h  C D 2 5 ,  w h i c h  g i v e s  a b i m o d a l  
p a t t e r n  o n l y  in t h e  t h r e e - s t a g e  m e t h o d ,  a n d  w i t h  C D 3 ,  w h i c h  s h o w s  a b r i g h t e r  p e a k  o f  p o s i t i v e  c e l l s  ( M F I = 2 0 6  
f o r  t h e  t h r e e - s t a g e  a n d  58 f o r  t h e  t w o - s t a g e  m e t h o d ) .  T h e  n e g a t i v e  c o n t r o l s  a r e  n o t  i n c r e a s e d  by t h e  e x t r a  l a y e r  
o f  s t a i n i n g .  N o t e  t h a t  C y - 3  is not m e a s u r e d  e f f e c t i v e l y  w i t h  4 8 8  n m  e x c i t a t i o n  ( c o m p a r e  r e s u l t s  to F i g u r e  3). 
b o t h  a b l e  to d e t e c t  a s c a t t e r i n g  o f  c e l l s  in the T c e l l  z o n e  e x p r e s s i n g  r e l a t i v e l y  h i g h  
a m o u n t s  o f  C D 2 5 ,  b u t  i m m u n o f l u o r e s c e n c e  d e t e c t e d  in a d d i t i o n  a l a r g e r  n u m b e r  o f  
w e a k l y - s t a i n e d  c e l l s  d i s t r i b u t e d  t h r o u g h o u t  T a n d  B c e l l  a r e a s .  
Expression of receptors on lymphoid tissue sections 
T h e  e x p r e s s i o n  o f  a n u m b e r  o f  c y t o k i n e  r e c e p t o r s  w a s  e x a m i n e d  in h u m a n  t o n s i l ,  
s p l e e n ,  i l e u m ,  g u t - a s s o c i a t e d  l y m p h  n o d e  a n d  a p p e n d i x .  T a b l e  2 s u m m a r i s e s  the 
d i s t r i b u t i o n  o f  s t a i n i n g  in t o n s i l ,  w h i c h  was s t u d i e d  m o s t  e x t e n s i  v e l y  (3 d i f f e r e n t  t o n s i l s ,  
5 s e p a r a t e  s t a i n i n g  e x p e r i m e n t s ) ,  w h i l s t  T a b l e  3 s u m m a r i s e s  the r e s u l t s  o b t a i n e d  o n  a 
n u m b e r  o f  d i f f e r e n t  t i s s u e s  f r o m  t h e  s a m e  i n d i v i d u a l .  S o m e  o f  the o b s e r v a t i o n s  a r e  
i l l u s t r a t e d  in F i g u r e  5 a n d  F i g u r e  4 . F o r  s o m e  a n t i b o d i e s ,  t h e  m i c r o s c o p e  s t u d i e s  w e r e  
e x t e n d e d  u s i n g  f l o w  c y t o m e t r i c  a n a l y s i s  o f  t o n s i l  c e l l  s u s p e n s i o n s .  
C D  121 a ( I L - l  r e c e p t o r  T y p e  I) s h o w e d  s t r o n g  s t a i n i n g  o f  v a s c u l a r  e n d o t h e l i u m  in 
t o n s i l  ( F i g u r e  Sa), b u t  v a s c u l a r  e n d o t h e l i u m  in s p l e e n  w a s  s t a i n e d  o n l y  w e a k l y .  I n  the 
l y m p h o i d  a r e a s ,  t h e r e  was m o d e r a t e  s t a i n i n g  o f  c e l l s  in the T c e l l  z o n e  ( F i g u r e  Sa), t h e  
f o l l i c u l a r  m a n t l e  a p p e a r e d  s l i g h t l y  b r i g h t e r  t h a n  t h e  T c e l l  z o n e ,  a n d  G C  w e r e  u s u a l l y  
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2 (A) 
2 (B) 
F i g u r e  2. C o m p a r i s o n o f  t w o - s t a g e  a n d  t h r e e - s t a g e  s t a i n i n g  in t o n s i l  s e c t i o n s .  T o n s i l  w a s  s t a i n e d  w i t h  a n t i -
[ g O  b y  t h e  t w o  p r o c e d u r e s ;  t h e  t h r e e - s t a g e  p r o c e d u r e  ( B )  s h o w e d  m u c h  b r i g h t e r  s t a i n i n g  t h a n  t h e  t w o - s t a g e  
p r o c e d u r e ( A l .  





F i g u r e  3 .  F l o w  c y t o m e t r i c  a n a l y s i s  o f  n o r m a l  b l o o d  l y m p h o c y t e s  ( g a t e d  on f o r w a r d  a n d  o r t h o g o n a l  l i g h t  
s c a t t e r ,  t o p  l e f t  p a n e l ) .  S t a i n i n g  w a s  w i t h  t h e  t h r e e - s t a g e  m e t h o d  u s i n g  PE. T h e  % v a l u e s  r e p r e s e n t  t h e  
p r o p o r t i o n  o f  l y m p h o c y t e s  s t a i n i n g  w i t h  e a c h  a n t i b o d y ,  a n d  m a y  b e  c o m p a r e d  w i t h  t h e  d a t a  o b t a i n e d  by 
m i c r o s c o p y  a f t e r  s t a i n i n g  t h e  s a m e  s a m p l e s  u s i n g  t h e  t h r e e - s t a g e  m e t h o d  w i t h  C y - 3 :  X 6 3 :  1.5 % ; C D 2 5 :  3 8 % : 
O K T 3 :  6 6 % .  
T a b l e  2. C y t o k i n e  r e c e p t o r  d i s t r i b u t i o n  i n  t o n s i l  s e c t i o n s  
R e c e p t o r  
I L - I  T y p e  I ( C D I 2 I a )  
I L - 2  a ( C D 2 5 )  
I L - 2  ~ ( C D I 2 2 )  
I L - 2  Y c h a i n  
I L A  ( C D  1 2 4 )  
T L - 6 ( C D I 2 6 )  
g p l 3 0  ( C D I 3 0 )  
I L - 7  ( C D w l 2 7 )  
T N F  t y p e  I ( C D  1 2 0 a )  
T N F  t y p e  2 ( C D 1 2 0 b )  
c - k i t  ( C D  I 17) 
T i s s u e  d i s t r i b u t i o n  
V a s c u l a r  e n d o t h e l i u m  bright, T - c e l l  z o n e  m o d e r a t e ,  g e n n i n a l  c e n t r e  n e g a t i v e  
W i d e s p r e a d  w e a k  s t a i n i n g ,  b r i g h t e r  T c e l l  z o n e ;  s c a t t e r e d  b r i g h t  c e l l s  
W e a k  s t a i n i n g  u n i f o r m l y  t h r o u g h o u t  t i s s u e  
W e a k  s t a i n i n g  u n i f o r m l y  t h r o u g h o u t  t i s s u e  
N e g a t i v e  
V e r y  w e a k  s t a i n i n g  
G e r m i n a l  c e n t r e  s t a i n e d  p r e f e r e n t i a l l y ,  s o m e  s t a i n i n g  i n  T c e l l  z o n e  
V e r y  w e a k  s t a i n i n g  
V e r y  w e a k  s t a i n i n g  
V e r y  w e a k  s t a i n i n g  
S c a t t e r e d  b r i g h t  c e l l s , m a i n l y  i n  c o n n e c t i v e  t i s s u e  
T a bl e 3. C o m p a r i s o n  o f  d i f f e r e n t l y m p h o i d  t i s s u e s . 
L y m p h o i d  T i s s u e s  
R e c e p t o r  S p l e e n  Il e u m T o n s i l L y m p h N o d e  (g u t) 
GC M E F  R E D G C  M E F  G C  M E F  G C  M E F  
I L -J t y p e l ( C D I 2 I a) + + + + ++ ++ + + 
I L - 2 a ( C D 2 5 )  2 + + 2 + +++ 2 + +++ 2 + +++ 
I L -2 ~ (C D I 22) ± + + + ± + + ± + + ± + + 
11- 2 y  ± ± + ± ± ± ± ± ± ± 
I L - 4 ( C D  124) 
I L - 6  ( C D  1 26) ± ± + + ± ± 
g p 1 3 0  ( C D 1 3 0 )  +++ - + +++ ++ + + ++ + + ++ + + 
Il- 7 ( C D 1 27) + ++ 
T N F  ty p e 1 ( C D I 2 0 a )  ± 
T N F  ty p e 2 ( C D I 2 0 b )  ± 3 ± 
c - k i t ( C D l 17) ± ± + 
G C  = g e r m i n a l c e nt re 
M = fo ll ic ul a r  m a n t l e 
E F  = ex t r a f o l l i c u l a r  a r e a  ( T  c e ll z o n e )  
R E D  = r e d  p u l p  o f  s p l e e n  ( s p l e n i c  c o r d s )  
D E G R E E  O F  S T A I N I N G :  - n e g a t i v e  
± v e r y  w e a k  
+ w e a k  
++ m o d e r a t e 
+++ h ig h 
' . 2 . ]  s c a t t e r e d b r i g h t l y s t a i n e d  c e ll s i n c o n n e c t i v e  t i ss u e '  o r  in g e r m i n a l c e nt re 2 ; a few m o d e r a t e l y - s t a i n e d  c e l l s  in T c e l l  a re a '-
A p p e n d i x 
G C  M E F  
+ + 
2 + ++ 
± + + 
± + 
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4 (a) 
4 (b) 
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4 (c) 
4 (d) 
F i g u r e  4 . C o m p a r i s o n  o f  i m m u n o p e r o x i d a s e  a n d  i m m u n o f l u o u r e s c e n c e .  F i g u r e s  4 a - c  a r e  i m m u n o p e r o x i d a s e  
s t a i n i n g ,  F i g u r e s  4 d - e  i m m u n o f l u o r e s c e n c e .  P a n e l s  a a n d  d s h o w  a n e g a t i v e  c o n t r o l  a n t i b o d y ,  p a n e l s  b a n d  
e s h o w  I g D  s t a i n i n g  o f  t h e  f o l l i c u l a r  m a n t l e , a n d  p a n e l s  c a n d  f s h o w  C D 2 5  s t a i n i n g  p r i n c i p a l l y  in the 
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4 ( e )  
4(f) 
e x t r a f o l l i c u l a r  T c e l l  z o n e .  P a n e l  f s h o w s  m o r e  w i d e s p r e a d  s t a i n i n g  t h a n  s e e n  in p a n e l  c ,  a l t h o u g h  t h e  m o s t  
s t r o n g l y - s t a i n e d  c e l l s  a r e  s e e n  b y  b o t h  m e t h o d s .  
158 H. Z O L A  ET AL. 
5 (a) 
5 (b) 
F i g u r e  5. E x a m p l e s o f  c y t o k i n e r e c e p t o r  e x p r e s s i o n in l y m p h o i d  ti s s u e .  S e e  T a h l e s 2 a n d  3 f o r d e t a i l .  F i g u r e 
5 a . I L - I  r e c e pt o r (CD 121 a )  on t o n s il , s h o w i n g  s t a i n i n g  o f  T c e l l  z o n e s a r o u n d  t h e  g e r m i n a l  c e n t r e ,  w h i c h i s 
u n s t a i n e d , a n d  s t r o n g  v e s s e l e n d o th e l i u m  s t a i n i n g . F i g u r e 5 b .  c - k i t  o n  t o n s i l , s h o w i n g bri g h t l y - s t a i n e d  c e ll s 
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5 (c) 
5 (d) 
s c a t t e r e d  t h r o u g h  e x t r a f o l l i c u l a r  a n d  c o n n e c t i v e  t i s s u e .  F i g u r e  5 c .  C D  1 3 0  o n  s p l e e n ,  s h o w i n g  s t a i n i n g  
p r i n c i p a l l y  in t h e  g e r m i n a l  c e n t r e .  F i g u r e  5 d .  C D 2 5  o n  g u t - a s s o c i a t e d  l y m p h - n o d e  t i s s u e ,  s h o w i n g  s c a t t e r e d  
b r i g h t  c e l l s  in g e r m i n a l  c e n t r e  a n d  s u r r o u n d i n g  T c e l l  z o n e .  
160 H. ZOLA ET AL. 
n e g a t i v e ,  a l t h o u g h  w e a k  s t a i n i n g  w a s  s e e n  in o n e  t o n s i l .  O b v i o u s  s t a i n i n g  o f  l y m p h o i d  
a r e a s ,  as w e l l  a s  b r i g h t  s t a i n i n g  o f  v e s s e l s , w a s  a l s o  s e e n  in t h e  o t h e r  l y m p h o i d  t i s s u e s .  
In s u s p e n s i o n ,  h o w e v e r , n o  p o s i t i v e  c e l l s  w e r e  s e e n  in the l y m p h o c y t e  p o p u l a t i o n . c - k i t  
was a l s o  n o t  d e t e c t e d  o n  l y m p h o i d  c e l l s  by f l o w  c y t o m e t r y , a l t h o u g h  in s e c t i o n s  s c a t t e r e d  
b r i g h t l y  s t a i n e d  c e l l s  w e r e  s e e n  in l y m p h o i d  a r e a s  ( F i g u r e  5 b ) , a n d  m o r e  a b u n d a n t l y  in 
c o n n e c t i v e  t i s s u e .  I L - 4 R  ( C D w I 2 4 )  w a s  n o t  s e e n  in s e c t i o n s ,  a l t h o u g h  we h a v e  
p r e v i o u s l y  d e m o n s t r a t e d  w e a k  s t a i n i n g  o f  a p r o p o r t i o n  o f  t o n s i l  B c e l l s  in s u s p e n s i o n  
s t u d i e s  ( 1 6 ) . T h e  I L - 6  r e c e p t o r  C D I 2 6  was s e e n  a t  v e r y  l o w  i n t e n s i t y  in t h e  G C  a n d  in 
e x t r a f o l l i c u l a r  a r e a s .  C D  130, w h i c h  t o g e t h e r  w i t h  C D  126 f o r m s the f u n c t i o n a l  I L - 6  
r e c e p t o r ,  s t a i n e d  m o r e  s t r o n g l y , w i t h  p r e f e r e n t i a l  l o c a l i z a t i o n  in t h e  G C  ( F i g u r e  5 c ) .  B y  
f l o w  c y t o m e t r y  ( F i g u r e  6) b o t h  C D  126 a n d  C D  1 3 0  w e r e  a s s o c i a t e d  p r i m a r i l y  w i t h  I g D -
n e g a t i v e , C D 2 3 - n e g a t i v e ,  C D 3 8  - p o s i t i v e  B c e l l s ,  w h i c h  a r e  p r i n c i p a l l y  G C  c e l l s .  C D  130 
s t a i n e d  v a s c u l a r  e n d o t h e l i u m , t h o u g h  n o t  as b r i g h t l y  as CD121 a . I L - 2  r e c e p t o r  s t a i n i n g  
was r a t h e r  u n i f o r m  f o r  all t h r e e  c h a i n s  o f  t h e  r e c e p t o r , a l t h o u g h  C D 2 5  s h o w e d  s t r o n g e r  
s t a i n i n g  in T c e l l  a r e a s ,  w i t h  s c a t t e r e d  b r i g h t  c e l l s  in the T c e l l  z o n e  ( F i g u r e  4 )  a n d  in the 
G C  ( F i g u r e  5 d ) .  F l o w  c y t o m e t r y  s h o w e d  no c l e a r  c o r r e l a t i o n  w i t h  s u b - p o p u l a t i o n s  
( F i g u r e  7). 
D I S C U S S I O N  
T h e  r e s u l t s  p r e s e n t e d  s h o w  t h a t  i m m u n o f l u o r e s c e n c e  s t a i n i n g  o f  t i s s u e  s e c t i o n s  c a n  
g i v e  s e n s i t i v i t y  c o m p a r a b l e  to f l o w  c y t o m e t r y  f o r  the d e t e c t i o n  o f  m o l e c u l e s  e x p r e s s e d  
a t  l o w  l e v e l s , in p a r t i c u l a r  c y t o k i n e  r e c e p t o r s .  S o m e  c y t o k i n e  r e c e p t o r s  w e r e  e x p r e s s e d  
at l e v e l s w h i c h  p r e c l u d e d  c l e a r  i n t e r p r e t a t i o n ,  b u t  t h e  s e n s i t i v i t y  w a s  g e n e r a l l y  g r e a t e r  
t h a n  t h a t  a c h i e v e d  u s i n g  i m m u n o e n z y m a t i c  m e t h o d s  a n d  the m e t h o d  t h e r e f o r e  p r o v i d e s  
an a d v a n c e  o n  e x i s t i n g  t e c h n i q u e s .  U s i n g  h i g h - s e n s i t i v i t y  m e t h o d s ,  the d i s t r i b u t i o n  o f  a 
n u m b e r  o f  c y t o k i n e  r e c e p t o r s  in s e c o n d a r y  l y m p h o i d  t i s s u e  c a n  b e  m a p p e d  a n d  p r o v i d e s  
s o m e  i n t e r e s t i n g  i n d i c a t i o n s  as to t h e i r  f u n c t i o n . 
I L - I  r e c e p t o r  ( T y p e  I) w a s  f o u n d  a s s o c i a t e d  w i t h  v a s c u l a r  e n d o t h e l i u m  a n d  was 
e x p r e s s e d  in the T c e l l  a r e a s  o f  l y m p h o i d  t i s s u e s . R e c e p t o r  e x p r e s s i o n  o n  v a s c u l a r  
e n d o t h e l i u m  h a s  b e e n  d e s c r i b e d ,  b a s e d  o n  s t u d i e s  o f  c e l l s  in s u s p e n s i o n  ( A k e s o n  et aI. , 
1992; C o l o t t a  et at., 1 9 9 3 ) . A o r t i c  e n d o t h e l i a l  c e l l s  w e r e  f o u n d  to e x p r e s s  1 0 0 0 - 3 0 0 0  
c o p i e s  o f  the T y p e  I r e c e p t o r , a n d  no T y p e  II r e c e p t o r  ( A k e s o n  et aI. , 1 9 9 2 ) .  I L - l  r e c e p t o r  
on e n d o t h e l i a l  c e l l s  is f u n c t i o n a l , s i n c e  I L - l  i n c r e a s e s  I C A M  - I  e x p r e s s i o n  o n  e n d o t h e l i a l  
c e l l s ,  a n d  t h i s  c a n  b e  b l o c k e d  w i t h  a n t i b o d y  a g a i n s t  t h e  r e c e p t o r  ( A k e s o n  et aI., 1992). 
T h e  f a c t  t h a t  C D  121 a is d e t e c t a b l e  o n  t o n s i l  s e c t i o n s  b u t  not in s u s p e n s i o n  s t u d i e s  i s 
u n l i k e l y  to b e  d u e  t o  a d i f f e r e n c e  in s e n s i t i v i t y ,  s i n c e  o t h e r  r e c e p t o r s  w e r e  d e t e c t e d  
e q u a l l y  w e l l  by t i s s u e  a n d  s u s p e n s i o n  s t u d i e s  ( C D 2 5 )  o r  with g r e a t e r  s e n s i t i v i t y  in 
s u s p e n s i o n  ( l L - 4  r e c e p t o r ) . W e  w e r e  n o t  a b l e  to d e t e c t  s i g n i f i c a n t  e x p r e s s i o n  o f  I L - I R  
o n  c i r c u l a t i n g  b l o o d  c e l l s  in an e a r l i e r  s t u d y  ( Z o l a  et aI. , 1 9 9 3 d ) .  An a l t e r n a t i v e  
e x p l a n a t i o n  is t h a t  the I L - I  r e c e p t o r  is s t o r e d  i n t r a c e l l u l a r l y  ( a n d  is t h u s  a c c e s s i b l e  in 
s e c t i o n s  b u t  n o t  o n  the c e l l  s u r f a c e )  o r  t h a t  the r e c e p t o r  is l o s t  f r o m  t h e  c e l l  s u r f a c e  d u r i n g  
t h e  p r o c e s s i n g  o f  c e l l  s u s p e n s i o n .  T h e r e  is p u b l i s h e d  e v i d e n c e  f o r  s h e d d i n g  o f  the T y p e  
I r e c e p t o r  ( A r e n d  et at., 1 9 9 4 )  a n d  t h e  T y p e  II r e c e p t o r  (Colottaet aI. , 1993). T h e  p r e s e n c e  
o f  I L - I  R o n  m a n t l e  z o n e  c e l l s  is p a r t i c u l a r l y  i n t e r e s t i n g  in the l i g h t  o f  the e x p r e s s i o n  o f  
m e m b r a n e  I L - I  a s e l e c t i v e l y  in the f o l l i c u l a r  m a n t l e  a n d  e x t r a f o l l i c u l a r  a r e a s  ( Z o l a  et at., 
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F i g u r e  6. T w o - c o l o u r  a n a l y s i s  o f  C D  126 ( t o p  r o w )  a n d  C D l 3 0  ( b o t t o m  r o w )  a g a i n s t  B c e l l  s u b s e t  m a r k e r s  in 
t o n s i l :  C D 3 8  ( p r i m a r i l y  g e r m i n a l  c e n t r e  c e l l s ) ,  C D 2 3  ( p r i m a r i l y  f o l l i c u l a r  m a n t l e  c e l l s )  a n d  I g D  ( m a n t l e  a n d  
e x t r a - f o l l i c u l a r  B c e l l s ) .  
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F i g u r e  7. T h r e e - c o l o u r  a n a l y s i s  o f  e x p r e s s i o n  o f  C D 2 5 .  C D 2 5  ( v e r t i c a l  a x i s )  is p l o t t e d  a g a i n s t  f r o m  l e f t ,  t o p  
row: C D 3  (T c e l l  m a r k e r ) ,  C D  19 (B c e l l  m a r k e r ) ,  C D 3 8  a f t e r  g a t i n g  f o r  C D  1 9 - p o s i t i v e  c e l l s  (B c e l l s ) ,  b o t t o m  
r o w  f r o m  l e f t :  C D 2 3  on g a t e d  B c e l l s ,  I g D  on g a t e d  B c e l l s .  T h e  l o w e r  r i g h t  f i g u r e  s h o w s  a n e g a t i v e  c o n t r o l  
a n t i b o d y ,  i s o t y p e - m a t c h e d  f o r  t h e  C D 2 5  a n t i b o d y ,  a g a i n s t  C D 3 .  
162 H .  Z O L A  ET AL. 
I L - 2  r e c e p t o r s  s h o w e d  w e a k  u n i f o r m  s t a i n i n g  t h r o u g h o u t  t h e  l y m p h o i d  a r e a s ,  w i t h  t h e  
ex c h a i n  ( C D 2 5 )  s h o w i n g  s o m e w h a t  s t r o n g e r  g e n e r a l  s t a i n i n g  i n  T cell a r e a s ,  as well as 
a s c a t t e r i n g  o f  b r i g h t l y - s t a i n e d  c e l l s  in T c e l l  a r e a s  a n d  G c .  W e  h a v e  p r e v i o u s l y  s h o w n  
b y  h i g h - s e n s i t i v i t y  s t a i n i n g  t h a t  I L - 2 R  ex a n d  ~ c h a i n s  a r e  e x p r e s s e d  on a m u c h  l a r g e r  
p o p u l a t i o n  o f  c e l l s  than c a n  be d e t e c t e d  by c o n v e n t i o n a l  m e t h o d s  ( Z o l a  et al., 1989, 
1 9 9 0 c ) ,  a n d  t h e  y c h a i n  is a l s o  q u i t e  b r o a d l y  e x p r e s s e d  in c i r c u l a t i n g  c e l l s  ( I s h i i  et aI., 
1994). T h e  c e l l s  in t i s s u e  t h a t  e x p r e s s  h i g h  l e v e l s  o f  C D 2 5 ,  d e t e c t a b l e  as b r i g h t  c e l l s  in 
i m m u n o f l u o r e s c e n c e  and a l s o  s t a i n e d  by i m m u n o p e r o x i d a s e ,  a r e  l i k e l y  to be a c t i v a t e d  
c e l l s ,  s i n c e  C D 2 5  has a r a p i d  t u r n o v e r  ( S a y a r  et al., 1990). C e l l s  e x p r e s s i n g  l o w e r  l e v e l s  
o f  the 3 r e c e p t o r  c h a i n s  a r e  p o t e n t i a l l y  r e s p o n s i v e  to I L - 2 ,  e s p e c i a l l y  s i n c e  I L - 2  c a n  up-
r e g u l a t e  its o w n  r e c e p t o r  ( W a l d m a n n ,  1989). 
I L - 4  r e c e p t o r  w a s  n o t  d e t e c t e d  b y  m i c r o s c o p y ,  a l t h o u g h  we h a v e  p r e v i o u s l y  d e m o n -
s t r a t e d  e x p r e s s i o n  o f  this r e c e p t o r  on a s u b s e t  o f  B c e l l s  by flow c y t o m e t r y  ( Z o l a  et al., 
1993a). T h i s  d i f f e r e n c e  m a y  b e  t e c h n i c a l ,  a l t h o u g h ,  as d i s c u s s e d  a b o v e ,  t h e r e  is no 
e v i d e n c e  for a s y s t e m a t i c  d i f f e r e n c e  in s e n s i t i v i t y  b e t w e e n  o u r  t i s s u e  s e c t i o n  m e t h o d  a n d  
flow c y t o m e t r i c  m e t h o d .  
I L - 6  r e c e p t o r  g p 8 0  ( C D I 2 6 )  w a s  s e e n  at low l e v e l  in t h e  G c .  a n d  the g p 1 3 0  s i g n a l  
t r a n s c u t i o n  m o l e c u l e  (CD 130) w a s  a l s o  s e e n  p r i m a r i l y  in t h e  G c .  a t  s i g n i f i c a n t l y  h i g h e r  
level. A l t h o u g h  t h e  d i f f e r e n c e  in s t a i n i n g  i n t e n s i  ty f o r  t h e  t w o  c h a i n s  o f  t h e  I L - 6  r e c e p t o r  
m a y  s i m p l y  r e f l e c t  d i f f e r e n c e s  b e t w e e n  the a n t i b o d i e s ,  i t  d o e s  s u g g e s t  t h a t  GC c e l l s  m a y  
a l s o  use gp 130 f o r  o n e  o r  m o r e  o f  the c y t o k i n e s  t h a t  s h a r e  t h i s  s i g n a l l i n g  m o l e c u l e ,  
c i l l i a r y  n e u r o t r o p h i c  f a c t o r  ( C N T F ) ,  o n c o s t a t i n  M, l e u k a e m i a  i n h i b i t o r y  f a c t o r  ( L I F )  a n d  
I L - l l .  O n c e  r e a g e n t s  are a v a i l a b l e ,  it w o u l d  be i n t e r e s t i n g  to e x a m i n e  t h e  e x p r e s s i o n  o f  
the s p e c i f i c  r e c e p t o r s  f o r  t h e s e  m o l e c u l e s  in G C ,  a n d  the f u n c t i o n a l  r o l e  o f  t h e  
c o r r e s p o n d i n g  c y t o k i n e s  in t h e  G C  r e a c t i o n .  A u t s c h b a c h  et al. ( 1 9 9 3 )  a l s o  f o u n d  t h a t  
C D 1 3 0  w a s  m o r e  b r o a d l y  e x p r e s s e d  t h a n  C D 1 2 6 ;  t h e y  a t t r i b u t e d  G C  s t a i n i n g  w i t h  
C D  130 to f o l l i c u l a r  d e n d r i t i c  c e l l s .  T h e  r o l e  o f I L - 6  as a B c e l l  d i f f e r e n t i a t i o n  f a c t o r  a c t i v e  
in l a t e  s t a g e s  o f  d i f f e r e n t i a t i o n  ( K i s h i m o t o ,  1989) w o u l d  l e a d  to t h e  e x p e c t a t i o n  o f  I L -
6 r e c e p t o r  e x p r e s s i o n  on G C  B c e l l s ,  b u t  we h a v e  f o u n d  C D  126 to b e  p r e s e n t  at v e r y  l o w  
l e v e l s  a n d  o f t e n  n o t  d e t e c t a b l e  o n  t o n s i l  G C  c e l l s ,  b o t h  in s u s p e n s i o n  a n d  s e c t i o n  s t u d i e s .  
It m a y  be t h a t  I L - 6  a c t s  l a t e r ,  a f t e r  p l a s m a  c e l l  p r e c u r s o r s  h a v e  l e f t  t h e  G c .  
IL-7 r e c e p t o r  a n d  the t w o  T N F  r e c e p t o r s  w e r e  d e t e c t e d  at s u c h  l o w  l e v e l s  t h a t  
i n t e r p r e t a t i o n  o f  d i s t r i b u t i o n  w o u l d  be u n r e l i a b l e .  We h a v e  p r e v i o u s l y  d e m o n s t r a t e d  
s t r o n g  e x p r e s s i o n  o f  I L - 7 R  on p e r i p h e r a l  b l o o d  l y m p h o c y t e s ,  b u t  m u c h  l o w e r  e x p r e s s i o n  
on t o n s i l  c e l l s  in s u s p e n s i o n  ( Z o l a  et al., 1 9 9 3 d ) .  W e  a l s o  f o u n d  T N F  r e c e p t o r  T y p e  I 
p o s i t i v e  o n  c i r c u l a t i n g  l y m p h o c y t e s ,  p a r t i c u l a r l y  C D 4  c e l l s ,  b u t  r e l a t i v e l y  p o o r l y  
e x p r e s s e d  on t o n s i l  c e l l s  in s u s p e n s i o n  ( Z o l a  et al., 1 9 9 3 b ) .  We h a v e  n o t  b e e n  a b l e  t o  
d e t e c t  T N F  r e c e p t o r  II on c i r c u l a t i n g  o r  t i s s u e  l y m p h o c y t e s  ( Z o l a  et al., 1993d, 1 9 9 3 b ) .  
O u r  u n d e r s t a n d i n g  o f  c y t o k i n e  a c t i o n  c o m e s  f r o m  a n u m b e r  o f  e x p e r i m e n t a l  a v e n u e s ,  
m o s t  o f  t h e m  i n v o l v i n g  m o d e l s  w e l l  r e m o v e d  f r o m  p h y s i o l o g i c a l  s t a t e s .  W e  k n o w  w h a t  
c y t o k i n e s  c a n  do, f r o m  in vitro a c t i v a t i o n  e x p e r i m e n t s  a n d  f r o m  m i c e  o v e r - e x p r e s s i n g  t h e  
c y t o k i n e s .  W e  k n o w  s o m e t h i n g  a b o u t  t h e  p r o c e s s e s  f o r  w h i c h  i n d i v i d u a l  c y t o k i n e s  are 
e s s e n t i a l ,  f r o m  k n o c k - o u t  m i c e  a n d  f r o m  " e x p e r i m e n t s  o f  n a t u r e " ,  b u t  n e i t h e r  o f  t h e s e  
s o u r c e s  o f  i n f o r m a t i o n  t e l l s  us r e l i a b l y  w h a t  c y t o k i n e s  do p h y s i o l o g i c a l l y .  L y m p h o i d  
t i s s u e s  c a n  p r o v i d e  i m p o r t a n t  c l u e s ,  b e c a u s e  t h e y  c o n t a i n  r e s t i n g  c e l l s ,  p h y s i o l o g i c a l l y  
a c t i v a t e d  c e l l s ,  c e l l s  in t r a n s i t  a n d  c e l l s  l o c a l i s e d  in w e l l - d e f i n e d  f u n c t i o n a l l y  i n t e r -
r e l a t e d  a r e a s .  S t u d i e s  o f  c y t o k i n e  ( H o e f a k k e r  et al., 1993; A n d e r s s o n  et al., 1994) o r  
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c y t o k i n e  m R N  A ( E m i l i e  et ai., 1990) d i s t r i b u t i o n  in t i s s u e  h a v e  p r o v i d e d  c l u e s  as to t h e  
p h y s i o l o g i c a l  r e a c t i o n s  t h a t  d e p e n d  o n  c y t o k i n e s .  F o r  e x a m p l e ,  the p r e d o m i n a n t l y  e x t r a -
f o l l i c u l a r  l o c a l i z a t i o n  o f  c e l l s  p r o d u c i n g  I L - 2 ,  I L - 4 ,  I L - 6  a n d  I L - l O  ( A n d e r s s o n  et ai., 
1994; E m i l i e  et ai., 1 9 9 0 )  s u g g e s t  t h a t  t h e  p r i m a r y  r o l e s  o f  t h e s e  c y t o k i n e s  is n o t  in the 
G C ,  in s p i t e  o f  c u r r e n t  m o d e l s  w h i c h  s u g g e s t  t h a t  c l a s s  s w i t c h i n g  a n d  B c e l l  d i f f e r e n t i a -
t i o n ,  p r o c e s s e s  t h a t  are t h o u g h t  o f  as b e i n g  d r i v e n  by t h e s e  c y t o k i n e s ,  o c c u r  in t h e  G c .  
R e c e p t o r  e x p r e s s i o n  s t u d i e s  c a n  p r o v i d e  e s s e n t i a l  c o m p l e m e n t a r y  i n f o r m a t i o n  to 
c y t o k i n e  p r o d u c t i o n  d a t a ,  a n d  it is i n t e r e s t i n g  t h a t  I L - 2 R  w a s  d e t e c t e d  in t h e  G C ,  b u t  IL-
4 a n d  I L - 6 R  w e r e  n e g a t i v e  o r  w e a k  a n d  v a r i a b l e  r e s p e c t i v e l y .  T h e  f i n d i n g  o f I L - l  R in t h e  
m a n t l e  a n d  T c e l l  a r e a  c o m p l e m e n t s  t h e  d e m o n s t r a t i o n  ( A n d e r s s o n  et ai., 1994) o f  I L -
l a in t h e s e  s a m e  a r e a s .  We p r e v i o u s l y  d e m o n s t r a t e d  b y  flow c y t o m e t r y  t h a t  m e m b r a n e  
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